US Stock MarketDetailed Quotes

AXSM Axsome Therapeutics

Watchlist
  • 127.540
  • +1.130+0.89%
Close Feb 28 16:00 ET
  • 127.540
  • 0.0000.00%
Post 20:01 ET
6.22BMarket Cap-21.29P/E (TTM)

About Axsome Therapeutics Company

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview contain AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Company Profile

SymbolAXSM
Company NameAxsome Therapeutics
Listing DateNov 19, 2015
Issue Price9.00
Founded2012
CEODr. Herriot Tabuteau, M.D.
MarketNASDAQ
Employees683
Fiscal Year Ends12-31
AddressOne World Trade Center,22nd floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10007
Phone1-212-332-3241

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Herriot Tabuteau, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 9.90M
  • Mark Jacobson, M.A.
  • Chief Operating Officer
  • 4.04M
  • Nick Pizzie
  • Chief Financial Officer and Principal Accounting Officer
  • 3.57M
  • Lori Englebert
  • Executive Vice President, Product Strategy
  • --
  • Ari Maizel
  • Executive Vice President, Head of Commercial
  • --
  • Dr. Roger A. Jeffs, PhD
  • Lead Independent Director
  • 400.34K
  • Dr. Mark Coleman, M.D.
  • Independent Director
  • 427.84K
  • Dr. Susan Mahony, M.B.A.,PhD
  • Independent Director
  • 417.48K
  • Mark E. Saad
  • Independent Director
  • 405.34K
  • Hunter Murdock
  • General Counsel
  • 3.06M

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l Show More